Abstract: Chronic kidney disease (CKD) research is limited by the lack of convenient inducible models mimicking human CKD and its complications in experimental animals. We demonstrate that a soluble oxalate-rich diet induces stable stages of CKD in male and female C57BL/6 mice. Renal histology is characterized by tubular damage, remnant atubular glomeruli, interstitial inflammation, and fibrosis with the extent of tissue involvement depending on the duration of oxalate feeding. Expression profiling of markers and magnetic resonance imaging findings established to reflect inflammation and fibrosis parallel the histological changes. Within 3 weeks the mice reproducibly develop normochromic anemia, metabolic acidosis, hyperkalemia, FGF23 activation, hyperphosphatemia and hyperparathyroidism. In addition, the model is characterized by profound arterial hypertension as well as cardiac fibrosis that persist following the switch to a control diet. Together, this new model of inducible CKD overcomes a number of previous experimental limitations and should serve useful in research related to CKD and its complications. 
Introduction

63
Translational research in the area of chronic kidney disease (CKD) requires experimental 64 models that (1) can be induced in C57BL/6 mice as it represents the most commonly used 65 genetic background for gene manipulations, (2) reliably generate stable CKD, (3) result in CKD 66 within a relatively short time to limit the burden for animals and reduce housing costs, (4) XT2000iV hematology analyzer (Sysmex Deutschland GmbH, Norderstedt, Germany) in the 118 "capillary blood" mode using the option "CBC DIFF RET" as described previously (23) 
Clinical chemistry analyses
133
Inorganic phosphate (Pi) was analyzed using an AU480 Clinical chemistry analyzer Coulter GmbH, Krefeld, Germany) and adapted test kits provided by Beckman Coulter in either 135 undiluted or 1:2 with deionized water diluted EDTA-treated plasma samples as described 136 previously (24). Heparinized capillaries were filled with 100 µL of whole blood and subjected to 137 measurement of potassium and pH using a blood gas analyzer (ABL 835 Flex, Radiometer GmbH, 138 Willich, Germany). Following recovery, the diet was changed to synthetic calcium-and oxalate-free diet (0% Ca 0% 149 Oxalate, TD. 95027, Ssniff) for one week, followed by high oxalate diet (0% Ca 0.67% Oxalate, 
Results
227
A diet high in soluble oxalate induces stable CKD
228
Previous work from our groups suggests that intraperitoneal oxalate can induce acute 229 kidney injury (22), and a high oxalate diet can cause progressive renal failure (15). In the present 230 study we first examined the effects of duration of feeding a soluble oxalate diet on renal 231 function in C57BL/6 mice. Providing an oxalate diet induced a decline in GFR and an increase in 232 plasma BUN and creatinine (Fig. 1A-C ). Shorter duration of oxalate feeding followed by 233 switching to control diet induced less advanced stages of CKD as defined by GFR, plasma BUN 234 and creatinine (Fig. 1D-F) . Serial monitoring documented that these parameters peaked at the 235 end of oxalate feeding followed by mild recovery over the following 2 week period. Urinary 236 oxalate increased following a switch to a soluble oxalate as compared to control diet (Fig. 1G) 
237
but no renal or bladder stones were detected (images not shown). Similarly, we observed a 238 11 sharp increase in plasma oxalate levels followed by a reduction of plasma oxalate levels when 239 mice were switched back to control diet (Fig. 1H) . Therefore, while a diet high in soluble oxalate 240 was found to induce a progressive decline in renal function as previously reported (13) (Fig. 3A) . Expression profiling for markers of kidney injury, inflammation and 253 fibrosis were consistent with progressive kidney atrophy (Fig. 3B) . Female C57BL/6 mice 254 revealed similar findings with very low inter-individual variability (Fig. 4A-F) . Given the 255 increasing use of diagnostic imaging modalities to assess changes of renal morphology, we 256 performed magnetic resonance imaging (MRI) of kidneys from mice. As compared to mice 257 receiving a control diet, animals receiving an oxalate diet displayed an increase in kidney cortex 258 volume, T1-, T2-and T2*-relaxation times as well as a reduction of the apparent diffusion 259 coefficient in the cortex (Fig 5) . These significant differences in the cortex are known to be Oxalate-induced CKD in C57BL/6 mice demonstrates classical CKD complications 266 We next examined whether the mouse model displays human CKD complications.
267
Oxalate diet induced normochromic anemia (Fig. 6A) E) in addition to metabolic acidosis (Fig. 6F) . Bone marrow of femoral bones demonstrated no 271 oxalate crystal deposition of mice receiving an oxalate diet (Fig. 6G) . Furthermore, oxalate diet 272 induced arterial hypertension ( Fig. 7A and B) , which persisted after cessation of the oxalate-rich 273 diet ( Fig. 7C and D ). In addition, oxalate feeding induced cardiac fibrosis ( Fig. 7E and F The renal mass reduction models have been a mainstay of CKD studies (16). Unilateral 
